Gemmer Asset Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Gemmer Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$548.35 - $738.84 $72,382 - $97,526	-132 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$574.03 - $680.96 $4,592 - $5,447	-8 Reduced 5.71%	132 $80,000
Q2 2021 Jul 23, 2021	BUY	$472.8 - $558.54 $472 - $558	1 Added 0.72%	140 $78,000
Q2 2020 Jul 31, 2020	BUY	$493.32 - $643.92 $3,946 - $5,151	8 Added 6.11%	139 $87,000
Q3 2019 Oct 11, 2019	BUY	$273.46 - $318.39 $1,093 - $1,273	4 Added 3.15%	131 $36,000

Q2 2019 Jul 18, 2019	SELL	$299.6 - $414.82 $6,890 - $9,540	-23 Reduced 15.33%	127 $40,000
Q1 2018 May 11, 2018	SELL	$315.82 - $393.78 $9,474 - $11,813	-30 Reduced 16.67%	150 $52,000
Q4 2017 Jan 16, 2018	BUY	$358.63 - $469.95 $10,758 - $14,098	30 Added 20.0%	180 $68,000
Q3 2017 Oct 12, 2017	BUY	$431.38 - $504.0 $64,707 - $75,600	150	150 $67,000

1,437

82.1M

835K

1.46M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $114B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.